> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Posts Medtronic Endotracheal Tube Update
- URL: https://www.fdaweb.com/fda-posts-medtronic-endotracheal-tube-update/
- Published: 2024-02-21T12:00:00.000Z
- Updated: 2026-09-14T14:23:32.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5156401

FDA has posted a Medtronic customer letter with updated information for use, new training material, and unique device identifier information for its NIM CONTACT Reinforced EMG (electromyogram) Endotracheal Tube and NIM Standard Reinforced EMG Endotracheal Tube. The post [says](https://www.fda.gov/medical-devices/letters-health-care-providers/update-recommendations-certain-medtronic-electromyogram-endotracheal-tubes-and-risk-airway?utm%5Fmedium=email&utm%5Fsource=govdelivery) the updates include information on what to do when airway obstruction has occurred.

A 4/27/2022 [post](https://www.fda.gov/medical-devices/letters-health-care-providers/potential-risk-airway-obstruction-when-using-certain-electromyogram-endotracheal-tubes-letter-health?ref=fdaweb.com) said FDA was evaluating the potential risk of airway obstruction when using silicone-based EMG endotracheal tubes. “FDA has received reports describing serious adverse events and deaths for these devices after airway obstruction and ventilation failure,” the post said. “If the tube does not ventilate properly, patients may suffer oxygen deprivation, brain damage, or death.”